Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. Κυριότερες Ειδήσεις

   • 

     Insider Monkey on MSN.com

     bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies

     2 ημέρες Πριν από

   • 

     ETF Daily News

     Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $4.63

     1 ημέρα Πριν από

   • 

     Hampshire Chronicle on MSN.com

     Care company celebrates 10th anniversary

     14 ώρες Πριν από

   • Times News

     Bluebird conference set for March in Browns Summit

     The N.C. Bluebird Society has scheduled its annual conference, “May all your blues be birds,” on Friday and Saturday, March 21-22, at the Haw River Conference Center,

     20 ώρες Πριν από

   • laingbuissonnews

     Bluebird Care expands offering as part of rebrand

     2 εβδομάδες Πριν από

2. www.reuters.com › business › healthcare-pharmaceuticalsBluebird's $2.8 million gene therapy becomes most expensive drug...

   www.reuters.com › business › healthcare-pharmaceuticals

   18 Αυγ 2022 · The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare disorder requiring regular blood transfusions, and the drugmaker priced it at a...

3. www.nytimes.com › 2024/05/06 › healthFirst Patient Begins Newly Approved Sickle Cell Gene Therapy

   www.nytimes.com › 2024/05/06 › health

   6 Μαΐ 2024 · Kendric Cromer, 12, the first commercial patient for Bluebird Bio’s gene therapy to cure his sickle cell disease, in the hospital as his bone marrow stem cells were being removed for gene...

4. www.fiercepharma.com › pharma › after-missing-out-fda-voucher-bluebird-quicklyAfter missing out on FDA voucher, bluebird quickly raises funds...

   www.fiercepharma.com › pharma › after-missing-out-fda-voucher-bluebird-quickly

   19 Δεκ 2023 · Now, bluebird is hurrying to raise millions of dollars—through two separate avenues—to fund the launch of its new sickle cell disease gene therapy and others.

5. www.marketbeat.com › instant-alerts › nasdaq-blue-initiated-coverage-2024/11/02bluebird bio (NASDAQ:BLUE) Now Covered by Analysts at ... -...

   www.marketbeat.com › instant-alerts › nasdaq-blue-initiated-coverage-2024/11/02

   • Αποθηκευμένο αντίγραφο

   10 ώρες πριν · bluebird bio Price Performance. bluebird bio stock opened at $0.47 on Friday. The business's 50-day moving average price is $0.53 and its 200 day moving average price is $0.83. The company has a quick ratio of 0.57, a current ratio of 0.68 and a debt-to-equity ratio of 0.37.

6. finance.yahoo.com › quote › BLUEbluebird bio, Inc. (BLUE) Latest Stock News & Headlines - Yahoo...

   finance.yahoo.com › quote › BLUE

   Get the latest bluebird bio, Inc. (BLUE) stock news and headlines to help you in your trading and investing decisions.

7. www.msn.com › en-us › moneybluebird bio (BLUE): Promising Gene Editing Stock with FDA ... -...

   www.msn.com › en-us › money

   While bluebird bio, Inc. (NASDAQ:BLUE) faced Nasdaq non-compliance notices due to delayed financial filings, the company’s Q2 2024 revenue surged to $16.1 million, and a strong rebound is ...

8. www.reuters.com › business › healthcare-pharmaceuticalsBluebird bio's gene therapy for blood disorder gets FDA panel...

   www.reuters.com › business › healthcare-pharmaceuticals

   10 Ιουν 2022 · Bluebird bio's treatment for a rare blood disorder received backing from advisers to the U.S. Food and Drug Administration on Friday, in a vote of confidence in gene therapies and bolstering the...